Sample  Genomind® Professional PGx TM Results Report

The Genomind Professional PGx report is intended to aid clinicians in making personalized treatment decisions tailored to a patient’s genetic background and can help to inform psychiatric treatments that:

  1. Have lower risk for side effects and adverse events
  2. Are more likely to be effective
  3. Are optimally dosed

Review a sample results report below, including the genetic results summary and the drug interaction summary.

Gene Variations

The Genomind Professional PGx report provides clinicians with the patient’s genetic results and clinical significance of each gene. The gene results provide the patient genotype for each of the gene variants on our panel. The color coded genotype reflects the patients inherited alleles, or variants, at a particular location within the tested gene. The report also provides therapeutic implication information regarding the function of the tested gene variant and how the patient’s genotype may affect medications. The Alert/Caution and PGx Guided Option Icons and clinical impact provide information on gene drug interactions and guide medications choices.

Gene Drug Interaction Summary

Each patient report includes a gene-drug interaction summary. Genomind Professional PGx is a guide for clinicians in the selection of safe and appropriate medications based on the results of the report. The gene-drug interaction summary provides information about how the patient’s genetic profile interacts with medications commonly used in psychiatry. This summary table lists medications in alphabetical order by generic name and drug class.

Medication Interaction falls into two categories:

Summary Pages:

Diagnosis-specific Summary Pages will provide a visual plot of drugs and augmentation strategies for a particular condition. The visual plot will shift left or right based on known gene-drug interactions.

  • Alert/Caution: Drugs will shift to the left if a patient has genetic variations which may reduce efficacy, Increase likelihood of side effects, or alter drug metabolism absorption.
  • Standard Options: Drugs that are not shifted indicate that there are no gene-drug interactions for the patient.
  • PGx Guided Options: Drugs will be shifted to the right if the patient has genetic variations which may increase likelihood of efficacy.

I’ve been using the Genecept Assay® for over three years and found that it helps me select the right medications for patients so that they can start feeling better more quickly.

Suzanne H. Grantham, PMHNPPsychiatric Mental Health Nurse Practitioner

} ); } ( jQuery ) );